Acorda to go corporate headquarters to Ardsley Park life science campus Acorda Therapeutics.

Acorda programs to relocate all employees presently based at its area in Hawthorne, New York to the Ardsley facility.D., Acorda’s President and CEO. ‘Acorda has been based in Westchester County since 1998, where we are proud to have got contributed to creating a lively biotechnology community in New York. We are pleased that New York state, county and municipality and economic development groupings collaborated with us and BioMed to supply a cost-efficient solution that allows Acorda to remain based in Westchester County.’ Purchased by BioMed for about $18.0 million, excluding closing costs, the Ardsley Park life science campus comprises approximately 159, 800 square feet of laboratory and work place and 500, 000 square feet of future advancement and redevelopment potential that can accommodate multiple tenants.This different approach of making flu vaccines will better react to the demands of a flu outbreak. I am delighted that the collaboration with Cytos is certainly making a meaningful contribution to Singapore's pandemic readiness, a crucial facet of our national security. The success of this potential vaccine will become of significant impact not merely to the region but also the world.’ Christian Itin , PhD, Chairman and Chief Executive Officer of Cytos, commented, ‘We have become happy with the fruitful collaboration which includes resulted in the clinical begin of this novel influenza vaccine. That is a significant milestone for the program and the initial clinical plan using Cytos' B-cell vaccine platform for a prophylactic vaccine against an infectious disease.’ Professor Alex Matter , Chief Executive Officer of D3 and A*STAR's Experimental Therapeutics Centre said, ‘If this VLP-vaccine technique proves to work, it can accelerate the production of vaccines against new emerging strains of flu.